ESC Professional Premium Access

Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction

Congress Presentation

About the speaker

Doctor Jonathan Cunningham

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)

6 more presentations in this session

Impact of inflammatory phenotype on prognostic discrimination for the novel biomarker cellular communication network factor 1 (CCN1) in patients with dilated cardiomyopathy

Speaker: Doctor R. Klingenberg (Bad Nauheim, DE)


NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy

Speaker: Doctor O. Wozniak (Warsaw, PL)


Vascular endothelial factor C and D in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction: the PREHOSP-CHF Study

Speaker: Doctor M. Iguchi (Kyoto, JP) Professor K. Hasegawa (Kyoto, JP)


Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure

Speaker: Doctor R. Pistulli (Munster, DE)


Heart failure is associated with low circulating levels of secreted frizzled receptor protein 5 (Sfrp5).

Speaker: Mr C. Kelly (Newcastle, AU)


Access the full session

Biomarkers for heart failure 1

Speakers: Doctor J. Cunningham, Doctor R. Klingenberg, Doctor O. Wozniak, Doctor M. Iguchi, Professor K. Hasegawa...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb